Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 39


MSA-C or SCA 17? A clinicopathological case update.

Doherty KM, De Pablo-Fernandez E, Houlden H, Polke JM, Lees AJ, Warner TT, Holton JL.

Mov Disord. 2016 Oct;31(10):1582-1584. doi: 10.1002/mds.26741. No abstract available.


A Rare Cause of Myoclonus: A Cupric Conundrum.

Doherty KM, Shields J, Forbes R, Gray M, Kearney S, Maxwell AP, McKinley J.

JAMA Neurol. 2016 Sep 1;73(9):1145-8. doi: 10.1001/jamaneurol.2016.1553.


Deletions at 22q11.2 in idiopathic Parkinson's disease: a combined analysis of genome-wide association data.

Mok KY, Sheerin U, Simón-Sánchez J, Salaka A, Chester L, Escott-Price V, Mantripragada K, Doherty KM, Noyce AJ, Mencacci NE, Lubbe SJ; International Parkinson's Disease Genomics Consortium (IPDGC)., Williams-Gray CH, Barker RA, van Dijk KD, Berendse HW, Heutink P, Corvol JC, Cormier F, Lesage S, Brice A, Brockmann K, Schulte C, Gasser T, Foltynie T, Limousin P, Morrison KE, Clarke CE, Sawcer S, Warner TT, Lees AJ, Morris HR, Nalls MA, Singleton AB, Hardy J, Abramov AY, Plagnol V, Williams NM, Wood NW.

Lancet Neurol. 2016 May;15(6):585-96. doi: 10.1016/S1474-4422(16)00071-5.


Concomitant fragile X-associated tremor ataxia syndrome and Parkinson's disease: a clinicopathological report of two cases.

De Pablo-Fernandez E, Doherty KM, Holton JL, Revesz T, Djamshidian A, Limousin P, Bhatia KP, Warner TT, Lees AJ, Ling H.

J Neurol Neurosurg Psychiatry. 2015 Aug;86(8):934-6. doi: 10.1136/jnnp-2014-309460. No abstract available.


Bone health in Parkinson's disease: a systematic review and meta-analysis.

Torsney KM, Noyce AJ, Doherty KM, Bestwick JP, Dobson R, Lees AJ.

J Neurol Neurosurg Psychiatry. 2014 Oct;85(10):1159-66. doi: 10.1136/jnnp-2013-307307. Review.


Late onset ataxia: MSA-C or SCA 17? A gene penetrance dilemma.

Doherty KM, Warner TT, Lees AJ.

Mov Disord. 2014 Jan;29(1):36-8. doi: 10.1002/mds.25770. No abstract available.


Parkin disease and the Lewy body conundrum.

Doherty KM, Hardy J.

Mov Disord. 2013 Jun;28(6):702-4. doi: 10.1002/mds.25486. No abstract available.


Pisa syndrome in Parkinson's disease: a mobile or fixed deformity?

Doherty KM, Davagnanam I, Molloy S, Silveira-Moriyama L, Lees AJ.

J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1400-3. doi: 10.1136/jnnp-2012-304700.


Parkin disease: a clinicopathologic entity?

Doherty KM, Silveira-Moriyama L, Parkkinen L, Healy DG, Farrell M, Mencacci NE, Ahmed Z, Brett FM, Hardy J, Quinn N, Counihan TJ, Lynch T, Fox ZV, Revesz T, Lees AJ, Holton JL.

JAMA Neurol. 2013 May;70(5):571-9. doi: 10.1001/jamaneurol.2013.172.


Primary progressive aphasia with parkinsonism.

Doherty KM, Rohrer JD, Lees AJ, Holton JL, Warren J.

Mov Disord. 2013 Jun;28(6):741-6. doi: 10.1002/mds.25341.


Loss of a 20S proteasome activator in Saccharomyces cerevisiae downregulates genes important for genomic integrity, increases DNA damage, and selectively sensitizes cells to agents with diverse mechanisms of action.

Doherty KM, Pride LD, Lukose J, Snydsman BE, Charles R, Pramanik A, Muller EG, Botstein D, Moore CW.

G3 (Bethesda). 2012 Aug;2(8):943-59. doi: 10.1534/g3.112.003376.


Decision making, impulsivity, and addictions: do Parkinson's disease patients jump to conclusions?

Djamshidian A, O'Sullivan SS, Sanotsky Y, Sharman S, Matviyenko Y, Foltynie T, Michalczuk R, Aviles-Olmos I, Fedoryshyn L, Doherty KM, Filts Y, Selikhova M, Bowden-Jones H, Joyce E, Lees AJ, Averbeck BB.

Mov Disord. 2012 Aug;27(9):1137-45. doi: 10.1002/mds.25105.


Camptocormia: don't forget muscle disease in the movement disorder clinic.

Doherty KM, Silveira-Moriyama L, Giladi N, Bhatia KP, Parton M, Lees AJ.

J Neurol. 2012 Aug;259(8):1752-4. doi: 10.1007/s00415-012-6448-z. No abstract available.


A multifaceted analysis of HIV-1 protease multidrug resistance phenotypes.

Doherty KM, Nakka P, King BM, Rhee SY, Holmes SP, Shafer RW, Radhakrishnan ML.

BMC Bioinformatics. 2011 Dec 15;12:477. doi: 10.1186/1471-2105-12-477.


Globular glial tauopathies (GGT) presenting with motor neuron disease or frontotemporal dementia: an emerging group of 4-repeat tauopathies.

Ahmed Z, Doherty KM, Silveira-Moriyama L, Bandopadhyay R, Lashley T, Mamais A, Hondhamuni G, Wray S, Newcombe J, O'Sullivan SS, Wroe S, de Silva R, Holton JL, Lees AJ, Revesz T.

Acta Neuropathol. 2011 Oct;122(4):415-28. doi: 10.1007/s00401-011-0857-4.


Familial camptocormia: from dystonia to myopathy.

Doherty KM, Noyce AJ, Silveira-Moriyama L, Nisbet A, Quinn N, Lees AJ.

J Neurol Neurosurg Psychiatry. 2012 Mar;83(3):350-1. doi: 10.1136/jnnp.2011.246561. No abstract available.


Postural deformities in Parkinson's disease.

Doherty KM, van de Warrenburg BP, Peralta MC, Silveira-Moriyama L, Azulay JP, Gershanik OS, Bloem BR.

Lancet Neurol. 2011 Jun;10(6):538-49. doi: 10.1016/S1474-4422(11)70067-9. Review.


Tetraplex binding molecules as anti-cancer agents.

Doherty KM, Sharma S, Gupta R, Brosh RM Jr.

Recent Pat Anticancer Drug Discov. 2006 Jun;1(2):185-200. Review.


Cutaneous reactions to drugs in children.

Segal AR, Doherty KM, Leggott J, Zlotoff B.

Pediatrics. 2007 Oct;120(4):e1082-96. Review.


Inhibition of BACH1 (FANCJ) helicase by backbone discontinuity is overcome by increased motor ATPase or length of loading strand.

Gupta R, Sharma S, Doherty KM, Sommers JA, Cantor SB, Brosh RM Jr.

Nucleic Acids Res. 2006;34(22):6673-83.

Items per page

Supplemental Content

Loading ...
Support Center